OFFICE SPACE LEASE For Suite 450 at 1000 CONTINENTAL DRIVE by and between EOS AT 1000 CONTINENTAL, LLC, (as Landlord) And NABRIVA THERAPEUTICS US, INC., (as Tenant) Date: 12.01.2014Office Space Lease • June 18th, 2015 • Nabriva Therapeutics AG • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJune 18th, 2015 Company Industry JurisdictionIn addition to other terms elsewhere defined in this Lease, the following terms whenever used in this Lease shall have only the meanings set forth in this Section, unless such meanings are expressly modified, limited or expanded elsewhere in this Lease.
EMPLOYMENT AGREEMENTEmployment Agreement • June 18th, 2015 • Nabriva Therapeutics AG • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJune 18th, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), is made as of December 1st, 2014 by and between Nabriva Therapeutics US, Inc. (the “Company”), and Steven Gelone (the “Executive”) (together, the “Parties”).
ENGLISH TRANSLATION FOR INFORMATIONAL PURPOSESLease Agreement • June 18th, 2015 • Nabriva Therapeutics AG • Pharmaceutical preparations
Contract Type FiledJune 18th, 2015 Company Industry
AGREEMENT FOR THE PROVISION OF A LOAN FACILITY OF UP TO €5,000,000 Dated 2014 BetweenLoan Agreement • June 18th, 2015 • Nabriva Therapeutics AG • Pharmaceutical preparations
Contract Type FiledJune 18th, 2015 Company IndustryKREOS CAPITAL IV (UK) LIMITED a company incorporated in England whose registered office is at 25-28 Old Burlington Street, London W1S 2AN (the “Lender”, which expression shall include its successors and assigns);
SHAREHOLDERS AGREEMENT 2015 Nabriva Therapeutics AG and the Shareholders thereof being Sandoz GmbH Gerd Ascher Rodger Novak Intertrust Trustees Ltd Ralf Schmid William Prince ARAX 2009.eins Private Equity GmbH & Co KG ARAX 2010 Private Equity GmbH &...Shareholder Agreement • June 18th, 2015 • Nabriva Therapeutics AG • Pharmaceutical preparations
Contract Type FiledJune 18th, 2015 Company Industryboard consists of more than one person, the company shall be represented by two members of the management board collectively or by one member of the management board jointly with a Prokurist (special agent). The supervisory board is entitled to vest members of the management board with single representation power.